During the course of our screening program for new antitumor antibiotics, we have recently isolated three active substances which were named kerriamycins A, B and C, respectively, from the culture broth of a streptomycete. These antibiotics inhibit the growth of Gram-positive bacteria and prolong the survival periods of mice bearing Ehrlich ascites carcinoma.